Ország: Svédország
Nyelv: svéd
Forrás: Läkemedelsverket (Medical Products Agency)
metadonhydroklorid
2care4 Generics ApS
N07BC02
methadone hydrochloride
5 mg
Tablett
laktosmonohydrat Hjälpämne; metadonhydroklorid 5 mg Aktiv substans
Receptbelagt
Förpacknings: Blister, 10 tabletter; Blister, 15 tabletter; Blister, 20 tabletter; Blister, 25 tabletter; Blister, 30 tabletter; Blister, 35 tabletter; Blister, 40 tabletter; Blister, 45 tabletter; Blister, 50 tabletter; Blister, 55 tabletter; Blister, 60 tabletter; Blister, 65 tabletter; Blister, 70 tabletter; Blister, 75 tabletter; Blister, 80 tabletter; Blister, 85 tabletter; Blister, 90 tabletter; Blister, 95 tabletter; Blister, 100 tabletter; Burk, 25 tabletter; Burk, 100 tabletter; Burk, 200 tabletter
Godkänd
2018-09-13
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT METADON 2CARE4 5 MG TABLETS METADON 2CARE4 10 MG TABLETS methadone hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What {Invented name} is and what it is used for 2. What you need to know before you take {Invented name} 3. How to take {Invented name} 4. Possible side effects 5. How to store {Invented name} 6. Contents of the pack and other information 1. WHAT {INVENTED NAME} IS AND WHAT IT IS USED FOR {Invented name} is a morphine-like medicinal product which is used in adults for: - treating severe chronic pain which can be adequately managed only with opioid analgesics. - substitution therapy in opiate dependent patients, given together with medical and psychological treatment and social rehabilitation. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE {INVENTED NAME} DO NOT TAKE {INVENTED NAME}: - if you are allergic to methadone or any of the other ingredients of this medicine (listed in section 6). - if you use or have used a monoamino-oxidase inhibitor (MAO-inhibitor) within the last two weeks (medicine used in the treatment of depression and Parkinson's disease). - if you have respiratory depression with slow and shallow breathing, or other acute breathing difficulties (acute obstructive airway disease). WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking {Invented name}, if you: - get acute asthma attacks, - suffer from lung disease or breathing difficulties, - have a heart disorder or ischemic heart disease, - have a li Olvassa el a teljes dokumentumot
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Metadon 2care4 5 mg tablets Metadon 2care4 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 mg tablet contains 5 mg of methadone hydrochloride. Each 10 mg tablet contains 10 mg of methadone hydrochloride. Excipient with known effect Each 5 mg tablet contains 157 mg lactose monohydrate per tablet. Each 10 mg tablet contains 71 mg lactose monohydrate per tablet. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet {Invented name} 5 mg tablets are white to almost white, round and flat 8 mm diameter tablets with the marking ‘5’ on one side and score line on the other side. The tablet can be divided into equal doses. {Invented name} 10 mg tablets are white to almost white, round and flat 6 mm diameter tablets with the marking ‘10’ on one side and score line on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic maintenance treatment of opioid-dependent patients in parallel with medical and psychological treatment and social rehabilitation. Symptomatic treatment of severe chronic pain, which can be adequately managed only with opioid analgesics. {Invented name} is indicated in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Pain conditions The dosage should be adjusted and evaluated based on the effect for the individual patient. The following dosage recommendations should only be considered as suggested approaches when treatment with {Invented name} is initiated and must be adjusted to the individual need for pain relief. In order to more rapidly achieve a full analgesic effect {Invented name} may initially be dosed with shorter dosage interval during a limited period. _Dose in opioid naive patient_ When oral methadone is used in patients who have not already been treated with opioids, the usual initial dose is 5 mg 1-3 times/day. This is followed by slow Olvassa el a teljes dokumentumot